Review the side-effects of Sipuleucel-T Suspension as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

Learn everything you need to know about Sipuleucel-T Suspension-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects ...

At the same time, certain side effects such as fever occur more frequently. Antigen cells are activated and infused back into the patient Treatment with sipuleucel-T aims to stimulate the immune ...

Sipuleucel-T in prostate cancer: Added benefit is not proven Data on mortality are not meaningfully interpretable; certain side effects occur more frequently ...

If you have side effects from sipuleucel-T, they usually start after you get the IV of the treated cells. The most common side effects from sipuleucel-T are like the flu: Chills; ...

However, these side effects were non-serious and mainly occurred only directly after the administration of sipuleucel-T. IQWiG therefore did not downgrade the positive effect regarding mortality.

These side effects can be understood on the basis of immune mechanisms that lead to hyperactivation of T-cells. For example, cytokines cause nonspecific T-cell reactivity and diffuse effects.

Sipuleucel-T Retreatment May Benefit Men with mCRPC. John Schieszer | Publish Date June 5, 2013 . Tomasz Beer, MD ...

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. The German ...

However, these side effects were non-serious and mainly occurred only directly after the administration of sipuleucel-T. IQWiG therefore did not downgrade the positive effect regarding mortality.

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier ...

However, these side effects were non-serious and mainly occurred only directly after the administration of sipuleucel-T. IQWiG therefore did not downgrade the positive effect regarding mortality.